• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bio-Path Holdings (NQ: BPTH )

    2.000 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 2.000
    Bid (Size) 1.850 (1)
    Ask (Size) 2.180 (6)
    Prev. Close 2.000
    Today's Range 2.000 - 2.000
    52wk Range 0.3200 - 7.670
    Shares Outstanding 1,656,235
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning! 
    Via InvestorPlace
    Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase
    EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:BPTH),(NASDAQ:LGVN),(NASDAQ:SLS),(NYSE:BMY) EQNX::TICKER_END 
    Via FinancialNewsMedia

    Performance

    YTD
    +306.09%
    +306.09%
    1 Month
    -2.91%
    -2.91%
    3 Month
    -56.52%
    -56.52%
    6 Month
    +306.09%
    +306.09%
    1 Year
    +12.36%
    +12.36%

    More News

    Read More
    Onsemi Layoffs 2024: What to Know as Onsemi Cuts 1,000 Jobs
    Via InvestorPlace
    Topics Workforce
    Exposures Layoff
    Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase
    From FN Media Group LLC
    Via GlobeNewswire
    Why Bank of America Thinks Hasbro (HAS) Stock Can Gain 40% From Here
    Via InvestorPlace
    Why Is Bio-Path (BPTH) Stock Up 20% Today?
    Via InvestorPlace
    Why Bio-Path Stock Is Climbing Today
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress
    From Bio-Path Holdings, Inc.
    Via GlobeNewswire
    Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
    From Bio-Path Holdings, Inc.
    Via GlobeNewswire
    Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24
    Via Newsfile
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
    From Bio-Path Holdings, Inc.
    Via GlobeNewswire
    Dow Dips Over 300 Points; GameStop Shares Spike Higher
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Crude Oil Down Over 3%; US Construction Spending Falls In May
    Via Benzinga
    Exposures Fossil Fuels
    What's Going On With Bio-Path Stock?
    Via Benzinga
    Nasdaq Surges 150 Points; US Manufacturing PMI Rises In May
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual Meeting
    From Bio-Path Holdings, Inc.
    Via GlobeNewswire
    Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress
    From Bio-Path Holdings, Inc.
    Via GlobeNewswire
    Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
    From Bio-Path Holdings, Inc.
    Via GlobeNewswire
    BPTH Stock Earnings: Bio-Path Holdings Misses EPS for Q1 2024
    Via InvestorPlace
    Bio-Path Holdings Reports First Quarter 2024 Financial Results
    From Bio-Path Holdings, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.